UNITY Biotechnology’s Post

🔎 2024 Rare Disease Highlights Countdown: #4 In the complex world of chronic inflammatory demyelinating polyneuropathy (#CIDP), misdiagnosis remains a significant challenge with serious implications for patients. Research reveals that more than half of CIDP patients are initially misdiagnosed, delaying proper treatment. Even more troubling, nearly half of those diagnosed with CIDP don’t actually have the condition, potentially exposing them to unnecessary treatments and missed opportunities for accurate care. 🔗 Read the full story: https://bit.ly/4gvz8D8 #RareDisease #MedNews

🔍 Overcoming Cognitive Biases in Rare Disease Diagnosis In rheumatology, even the most experienced healthcare providers face cognitive biases when diagnosing rare diseases. The symptoms of rare rheumatic conditions often overlap with more common disorders, leading to misdiagnosis or delays in treatment. 🧠 Raising awareness and educating clinicians about these biases is crucial to ensure rare diseases aren’t overlooked. Together, we can sharpen our diagnostic skills and better serve patients with these complex conditions. #RareRheumaticDiseases #CognitiveBias #ImprovedDiagnosis #RheumatologyAwareness #RareRheum #RNS2024

We are delighted to share with you our latest milestone in IBD research published in the following publication: "The Inflammatory Bowel Disease Middle East Registry: Challenges Faced, and Lessons Learned from Setting Up a Multi-Country Patient Registry" This initiative represents a significant step forward in understanding and addressing the complexities of IBD management in the Middle East. For access to the article, click here; https://lnkd.in/dZCuRcVJ #IBD #Ulcerativecolitis #Outcomesresearch #realworldevidence

🎯 Key Insights on Rare Disease Diagnosis 🎯 A recently published article explores the complexities of diagnosing rare diseases, emphasizing the need for earlier recognition and more effective tracking of undiagnosed cases. It highlights the importance of developing a comprehensive coding framework that spans all stages of the diagnostic journey, aiming to improve patient care, reduce delays in treatment, and enhance support for both individuals and the broader community. Discover more about this critical advancement in rare disease management: https://lnkd.in/dim3pEtm #RareDiseases #HealthcareInnovation #MedicalResearch #PatientCare #HealthPolicy

What is Peripheral Arterial Disease (PAD)? PAD is a condition characterized by the narrowing of arteries, which reduces blood flow to the limbs and can lead to significant morbidity. Understanding the pathophysiology of PAD is essential for early diagnosis and effective treatment. Explore this link for an in-depth overview of PAD and a video demonstrating the impact of arterial narrowing on blood flow. Stay informed to provide the best care for your patients. #WhatIsPAD #HealthEducation #SSITogetherWeFightPAD2024 Visit semlerscientific.com for more information and resources to learn more about PAD.

As Semler Scientific®continues with their educational post about peripheral arterial disease (PAD) check out the video below for an in-depth overview of PAD and the impact of arterial narrowing.

Reaching the right patients with life-changing treatments for Sickle Cell Disease (SCD) is crucial. However, inaccurate target call lists can lead to wasted resources and delays in critical care. Discover how we helped a client develop a data-driven approach to create an accurate target call list for their SCD treatment. This led to improved patient identification, more efficient outreach, and faster access to care. Read the full case study here: https://hubs.li/Q02VYrLx0...

Now on Healio CME: "Thyroid Eye Disease: Unmasking and Taming What’s in Disguise" with Drs. Andrea Kossler and Jennifer Loh. In this CE monograph, experts in the field evaluate treatment strategies that exhibit a favorable risk-benefit profile to improve outcomes and patient satisfaction and review risk factors and classification criteria that aid in the timely differential diagnosis of TED. This activity is supported by educational funding provided by Amgen. Find it here: https://lnkd.in/e5xmvC2h

Traditional real-world data, such as data from claims and EHRs, misses a big part of your patients’ stories. Join experts from Evidation and rheumission to hear case studies and best practices for filling important blanks, specifically in autoimmune disease: https://gag.gl/IZTIEm #webinar #autoimmunedisease #autoimmune #RWD #RWE

Knowledge is power.,